News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Abstract Submissions for the ESMO 2025 Congress are open
ESMO/X
Apr 10, 2025, 11:43

Abstract Submissions for the ESMO 2025 Congress are open

ESMO shared a post on X:

“Your opportunity for global impact. Submit your abstract and share your findings with the world’s leading oncology experts.

Abstract deadline 13 May 2025.”

ESMO 2025 Congress
cancer ESMO ESMO 2025 Congress OncoDaily Oncology
Special Coverage
Blog
Jun 4, 2025, 00:35
Ruben Mesa: Important work in Pharmacogenomics around DPYD at ASCO25
Blog
Jun 4, 2025, 00:12
Dinesh Raj Neupane: Paying the Price for Distance: Travel-Driven Financial Toxicity Among Cancer Patients in Nepal
Blog
Jun 3, 2025, 20:49
Tracey O’Brien: Excited to Announce Speakers for the Inaugural NSW Cancer Summit 2025
Insight
Jun 3, 2025, 18:29
Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC
Insight
Jun 3, 2025, 18:25
From Political Will to Global Wake-Up Call: Hesham ElGhazaly on Egypt’s National Cancer Strategy at ASCO 2025
Insight
Jun 3, 2025, 18:19
Clifford Hudis and Thomas Kurian Discussed AI in Oncology and ASCO Guidelines Assistant at ASCO 2025
Insight
Jun 3, 2025, 18:18
Elizabeth McKenna: Study on Vascular Normalization and Enhanced Immunotherapy
Insight
Jun 3, 2025, 17:25
Mohammad Jad Moussa: Huge Congrats to My Future Co-Resident Sam Black on This ASCO 2025 Feat
Insight
Jun 3, 2025, 17:21
Nicolas Sayegh: Zeynep Irem Ozay Presented Real-World Data on Lutetium vs. Cabazitaxel in mCRPC at ASCO 2025
Insight
Jun 3, 2025, 16:58
Paolo Tarantino Presented DATO-Base Trial Poster at ASCO 2025 on Breast Cancer CNS Metastases
Insight
Jun 3, 2025, 16:39
Pashtoon Kasi: This Is the 1st Time I Started Hearing the Word “CURE” in Patients with Metastatic Stage-IV Cancers
Blog
Jun 3, 2025, 16:39
Massimo Di Maio: Standing Ovation for CHALLENGE phase 3 trial at ASCO25